Insulet (PODD) Total Current Liabilities (2010 - 2026)
Insulet's (PODD) quarterly Total Current Liabilities came in at $687.5 million in Q1 2026, up 32.11% YoY from $520.4 million in Q1 2025, and up 1.09% on a QoQ basis from $680.1 million in Q4 2025.
Insulet (PODD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Total Current Liabilities data on file, last reported at $687.5 million in Q1 2026.
- Quarterly Total Current Liabilities rose 32.11% year-over-year to $687.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $687.5 million (up 32.11% YoY) and the FY2025 annual result came in at $680.1 million, up 28.71% from the prior year.
- Total Current Liabilities improved to $687.5 million in Q1 2026, from $680.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.0 billion in Q2 2025 to a low of $215.0 million in Q1 2022.
- A 5-year average of $494.3 million and a median of $451.4 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities increased 12.14% — and 2025, when it soared 107.84%.
- Tracing PODD's Total Current Liabilities over 5 years: stood at $364.7 million in 2022, then increased by 23.72% to $451.2 million in 2023, then climbed by 17.11% to $528.4 million in 2024, then climbed by 28.71% to $680.1 million in 2025, then increased by 1.09% to $687.5 million in 2026.
- The last three Total Current Liabilities figures came in at $687.5 million (Q1 2026), $680.1 million (Q4 2025), and $647.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn | 744.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 744.20 Mn |
| Mar 31, 2026 | 687.50 Mn |
| Dec 31, 2025 | 680.10 Mn |
| Sep 30, 2025 | 647.70 Mn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 520.40 Mn |
| Dec 31, 2024 | 528.40 Mn |
| Sep 30, 2024 | 506.20 Mn |
| Jun 30, 2024 | 486.00 Mn |
| Mar 31, 2024 | 432.40 Mn |
| Dec 31, 2023 | 451.20 Mn |
| Sep 30, 2023 | 451.40 Mn |
| Jun 30, 2023 | 425.00 Mn |
| Mar 31, 2023 | 383.30 Mn |
| Dec 31, 2022 | 364.70 Mn |
| Sep 30, 2022 | 334.20 Mn |
| Jun 30, 2022 | 279.30 Mn |
| Mar 31, 2022 | 215.00 Mn |
| Dec 31, 2021 | 228.80 Mn |
| Sep 30, 2021 | 228.60 Mn |